GU Cancers 2019 | Key prostate cancer news from GU 2019

Name: Key prostate cancer news from GU 2019
Uploaded: 2019-02-15T00:00:00Z
Duration: 2 min 40 s
Description: Simon Crabb, MBBS, MRCP, PhD, of the University of Southampton, Southampton, UK, summarizes key prostate cancer news presented at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA. Dr Crabb reviews promising results from the LATITUDE study (NCT01715285), the ARCHES trial (NCT02677896) and the ARAMIS trial (NCT02200614).

Simon Crabb • 15 Feb 2019

GU Cancers 2019

Genitourinary Cancer Prostate Cancer Abiraterone Darolutamide Enzalutamide

ARAMIS ARCHES LATITUDE

Simon Crabb, MBBS, MRCP, PhD, of the University of Southampton, Southampton, UK, summarizes key prostate cancer news presented at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA. Dr Crabb reviews promising results from the LATITUDE study (NCT01715285), the ARCHES trial (NCT02677896) and the ARAMIS trial (NCT02200614).